However, Pozdeyev et al. noted presence of MMR DNA deficiency in up to 46% of thyroid cancers with high mutational burden especially ATCs, and these tumours lacked RAS, BRAF or RET oncogenes [18]. This evidence concerns the gene BRAF and thyroid cancer.